The WHRI’s Global Control of HPV Related Diseases Research Program made a significant mark at the 23rd STI & HIV 2019 World Congress held in Vancouver from July 14 – 17. The group led a well-attended pre-conference workshop and were selected for several oral and poster presentations throughout the conference.
Click through the title to read more.
Vaccines to prevent STIs
Ahead of Congress, B.C. researchers are convening an event focused on STI vaccines on July 14. The symposium will examine how vaccine hesitancy could impact attitudes and uptake of new STI vaccines. It will review experiences from the introduction of the human papilloma virus (HPV) vaccine that prevents certain types of cancers including most cervical cancers and how the lessons learned could give health care providers the tools to address vaccine hesitancy. It will also highlight research into the development of new vaccines to help curb increasing rates of STIs such as chlamydia, gonorrhoea, and syphilis.
The event is organized by the BC-based Sexually Transmitted Infections Vaccine Consortium (STRIVEBC) which includes researchers, clinicians and public health leaders from BC Women’s Hospital & Health Centre, BCCDC and the University of British Columbia.
Click through the title to read more.
